Oppenheimer analysts downgraded Pliant Therapeutics stock from Outperform to Perform, following a significant development ...

Reports of a potential merger of Cboe Global Markets' (BATS:CBOE) and CME Group (CME) could revive, due to a perceived lack of revenue growth drivers at Cboe and a relaxed attitude on M&A under the ...

Regal Rexnord (NYSE:RRX – Free Report) had its price objective reduced by Oppenheimer from $210.00 to $190.00 in a research note issued to investors on Friday,Benzinga reports. Oppenheimer currently ...

AUM and trading activity drives Oppenheimer's wealth management business. Read why we remain bullish on OPY stock.

Oppenheimer cut shares of Cloudflare (NYSE:NET – Free Report) from an outperform rating to a market perform rating in a research note issued to investors on Friday morning, Marketbeat reports. Several ...

Cillian Murphy’s dedication to Oppenheimer went beyond acting—he learned 30,000 words of Dutch, followed a brutal diet, and ...

(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...

Oppenheimer analyst Ken Wong lowered the firm’s price target on Bill (BILL) to $90 from $110 and keeps an Outperform rating on the shares. The ...

Benny Safdie is the latest actor to join the cast of The Odyssey, the next movie from Christopher Nolan, according to The ...

Alphabet (GOOGL) will be stepping up to the earnings plate tomorrow (February 4), when it will deliver its fourth quarter ...

Oppenheimer downgraded Apple from "outperform" to "perform" because it is struggling to adapt to a competitive AI landscape.